尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Meury William, 董事. Officer active across 4 companies, notably Syndax Pharmaceuticals Inc. Cumulatively, 12 disclosures have been published. Activity tracked since 2 February 2022. The latest transaction was disclosed on 16 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Meury William is Administrateur, and the filing history of 12 filings covers Syndax Pharmaceuticals Inc, INCYTE CORP and Karuna Therapeutics, Inc. In the recent filings we hold, the period runs from 2022-02-03 to 2026-07-20, with EUR 3136077 of buys, EUR 0 of sells, and the main transaction nature listed as Attribution.